Search details
1.
Evaluating programmed death-ligand 1 (PD-L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay on whole sections from a multicentre study.
Histopathology
; 80(2): 397-406, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34496080
Results
1 -
1
de 1
1
Next >
>>